Manning Linda Shapiro 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Sep 15, 2021
Insider Transaction Report
Form 4
Manning Linda Shapiro
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-10+15,000→ 15,000 totalExercise: $12.98Exp: 2031-09-09→ Common Stock (15,000 underlying) - Award
Restricted Stock Units
2021-09-10+2,500→ 2,500 total→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]The stock options were granted on September 10, 2021. 25% of the shares subject to the option will vest and become exercisable on September 10, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]The restricted stock units vest as to 25% of the total shares on each of September 10, 2022, September 10, 2023, September 10, 2024 and September 10, 2025. The restricted stock units have no expiration date.